Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRecursion Pharmaceuticals Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$0.31 | -$0.19 | -$0.27 |
| Q2 2026 | 5 | -$0.31 | -$0.18 | -$0.26 |
| Q3 2026 | 1 | -$0.40 | -$0.08 | -$0.25 |
| Q4 2026 | 1 | -$0.39 | -$0.08 | -$0.24 |
| Q1 2027 | 1 | -$0.39 | -$0.08 | -$0.25 |
| Q2 2027 | 1 | -$0.37 | -$0.07 | -$0.24 |
| Q3 2027 | 1 | -$0.36 | -$0.07 | -$0.23 |
| Q4 2027 | 1 | -$0.32 | -$0.06 | -$0.20 |
Recursion Pharmaceuticals Inc Earnings Date And Information
Recursion Pharmaceuticals Inc last posted its earnings results on Wednesday, May 6th, 2026. The company reported $-0.22 earnings per share for the quarter, topping analysts' consensus estimates of $-0.3 by $0.08. The company had revenue of 6.47 M for the quarter and had revenue of 74.68 M for the year. Recursion Pharmaceuticals Inc has generated $-1 earnings per share over the last year ($-1.44 diluted earnings per share) and currently has a price-to-earnings ratio of -3.2. Recursion Pharmaceuticals Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Recursion Pharmaceuticals Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/06/2026 | Q1 2026 | -$0.30 | -$0.22 | 0.08 | $15.79 M | $6.47 M |
| 02/25/2026 | Q4 2025 | -$0.28 | -$0.21 | 0.07 | $24.54 M | $35.54 M |
| 11/05/2025 | Q3 2025 | -$0.38 | -$0.36 | 0.02 | $16.95 M | $5.18 M |
| 08/05/2025 | Q2 2025 | -$0.35 | -$0.41 | -0.06 | $15.37 M | $19.10 M |
| 05/05/2025 | Q1 2025 | -$0.44 | -$0.50 | -0.06 | $14.98 M | $14.75 M |
| 02/28/2025 | Q4 2024 | -$0.44 | -$0.53 | -0.09 | $15.31 M | $4.51 M |
| 11/06/2024 | Q3 2024 | -$0.33 | -$0.34 | -0.01 | $18.72 M | $26.08 M |
| 08/08/2024 | Q2 2024 | -$0.35 | -$0.40 | -0.05 | $11.96 M | $14.40 M |
| 05/09/2024 | Q1 2024 | -$0.43 | -$0.39 | 0.04 | $11.10 M | $13.49 M |
| 02/29/2024 | Q4 2023 | N/A | -$0.40 | N/A | N/A | $10.62 M |
| 11/09/2023 | Q3 2023 | -$0.38 | -$0.43 | -0.05 | N/A | $10.10 M |
| 08/08/2023 | Q2 2023 | -$0.38 | -$0.38 | 0 | N/A | $11.02 M |
| 05/08/2023 | Q1 2023 | -$0.34 | -$0.32 | 0.02 | N/A | $12.13 M |
| 02/27/2023 | Q4 2022 | -$0.15 | -$0.31 | -0.16 | N/A | $13.68 M |
| 11/08/2022 | Q3 2022 | -$0.36 | -$0.34 | 0.02 | N/A | $13.05 M |
| 08/09/2022 | Q2 2022 | -$0.35 | -$0.38 | -0.03 | N/A | $7.65 M |
| 05/10/2022 | Q1 2022 | $0.51 | -$0.33 | -0.84 | N/A | $5.30 M |
| 03/23/2022 | Q4 2021 | -$0.30 | -$0.38 | -0.08 | N/A | $2.50 M |
| 11/10/2021 | Q3 2021 | -$0.28 | -$0.28 | 0 | N/A | $2.50 M |
| 08/13/2021 | Q2 2021 | -$0.23 | -$0.26 | -0.03 | N/A | $2.50 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Recursion Pharmaceuticals Inc Earnings: FAQ's
In the previous quarter, Recursion Pharmaceuticals Inc (:RXRX) reported $-0.22 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.3 by $0.08.
The conference call for Recursion Pharmaceuticals Inc's latest earnings report can be listened to online.
The conference call transcript for Recursion Pharmaceuticals Inc's latest earnings report can be read online.
Recursion Pharmaceuticals Inc (:RXRX) has a recorded annual revenue of $74.68 M.
Recursion Pharmaceuticals Inc (:RXRX) has a recorded net income of $-644,759,000.Recursion Pharmaceuticals Inc has generated $-1.44 earnings per share over the last four quarters.
Recursion Pharmaceuticals Inc (:RXRX) has a price-to-earnings ratio of -3.2 and price/earnings-to-growth ratio is -0.08.